Frequently asked questions.

Start from the national anchors: the mean Step 2 CK score was 249 in 2023–24, the passing standard is 218 (raised July 2025), and matched U.S. MD seniors in the 2024 Match averaged 250.4 (SD 13.2). Then look at the observed 2024 match rates by score band for specialties you're considering — our Match Data page shows five specialties with full caveats. Notice the shape: some specialties barely respond to score (pediatrics), others respond strongly and continuously (orthopaedic surgery, dermatology). The honest answer to "what score do I need" is a range plus a margin, worked out with your school advisor — not a single magic number. And remember the population caveats: those band rates are observed outcomes for 2024 U.S. MD seniors matched to their preferred specialty, not predicted probabilities for you.

Step 1 became pass/fail in January 2022, removing the scored number programs had used as their primary screen. The screening role moved to Step 2 CK: the 2024 NRMP Program Director Survey found it the 4th most frequently considered factor in interview decisions, 30% of programs required a target Step 2 CK score for an interview, and 77% consider failed Step attempts. It's now the only scored exam whose result most applicants have before residency applications.

In general terms: after your core clinical rotations, with a dedicated study period, and early enough that the score is reported before ERAS applications are submitted — so programs can see the metric many use as an interview filter. But readiness matters as much as timing: self-assessment scores consistently below your target range are a signal to get advising before you sit, not after. Your school's advisors know your curriculum and your data — that's the right conversation. See the timeline page for the general sequence.

USMLE policy allows the exams to be taken in either order — but most schools sequence them (Step 1 first, then Step 2 CK after the clinical year), and many schools have policies about this. The far more common question underneath this one is "should I rush?" — and the answer is almost always no: Step 2 CK builds on clinical knowledge, so taking it before the clerkships that teach that knowledge is working against the test's design. Confirm your school's policy before planning anything unusual.

First: it is recoverable, but it is consequential. Nationally, repeat-taker pass rates are much lower than first-timer rates — roughly 74% for MD and 72% for DO repeat takers (USMLE Performance Data via NBME) — and the 2024 NRMP survey found 77% of program directors consider failed Step attempts when interviewing. That means a retake deserves serious preparation and advising, not a rushed second attempt. Talk to your school's academic support office early: they have seen this before and know what a strong retake plan looks like. Failing once does not end a medical career — but it does change the planning, and your advisor is the person to plan with.

USMLE policy generally does not permit retaking an exam you passed — a passing score stands. This is one reason score-target thinking matters before the exam rather than after: there is no "take it and see" safety net. Confirm current policy details at usmle.org, since policies can change.

The best available readiness signal is a trend across NBME self-assessments — official practice exams from the USMLE's co-sponsoring organization (nbme.org), taken under exam-like conditions. One assessment is a data point; a consistent trend in the range you need is a green light. If your trend is consistently below your target, treat it as information, not failure — and bring it to an advisor while there is still time to adjust the plan.

Shelf exams (NBME subject exams at the end of clerkships) are your earliest diagnostic for Step 2 CK. Each one tests a domain the exam covers, and a weak subject on a shelf is a weak subject on Step 2 CK — discovered months early, when there's time to fix it. Interpret each shelf score against that subject's national norms (for 2020–21 they ranged from about 74.8 for surgery to 84.9 for psychiatry, and within each year national means drift 2–3 points upward from August to May), not against a universal cutoff.

The score is a three-digit number reported on your USMLE transcript, with context about the passing standard (currently 218). Through ERAS, residency programs you apply to receive the scores you authorize. Score reports also include performance profiles by content area — useful feedback even before applications. Exact reporting timelines vary year to year; confirm current details at usmle.org.

No. Thirty percent of programs required a target Step 2 CK score for an interview in the 2024 NRMP survey — which means 70% did not. Less competitive specialties show observed match rates that barely respond to score (pediatrics was 97% even in the 211–220 band); highly competitive ones respond strongly (orthopaedics, dermatology). Programs also weigh clerkship grades, letters, MSPE narratives, research, and fit. The score is the one national, standardized number — which is why it gets the attention it does, not because it's the only thing that matters.

Both — they're different jobs. The clinical year builds the knowledge; dedicated study consolidates it. Daily question practice during rotations, treated seriously, is the foundation; a several-week dedicated period of timed blocks, explanation review, and NBME self-assessments is the polish. Students who skip the first job arrive at dedicated study trying to learn clinical medicine from scratch, and that's the single most common strategic mistake. See the strategy page.

For most applicants, yes: it's the last scored USMLE result available before residency applications. Step 3 is typically taken during residency itself, after the Match. That timing is exactly why Step 2 CK carries its current weight — it's the final scored data point programs have when they decide on interviews.